Yanwu You Selected Research

Chemokine CX3CL1

8/2022	Fractalkine deficiency attenuates LPS-induced acute kidney injury and podocyte apoptosis by targeting the PI3K/Akt signal pathway.
1/2021	Depletion of Fractalkine ameliorates renal injury and Treg cell apoptosis via the p38MAPK pathway in lupus-prone mice.
1/2021	Fractalkine aggravates LPS-induced macrophage activation and acute kidney injury via Wnt/β-catenin signalling pathway.
1/2020	Fractalkine mediates lymphocyte inflammation and tubulointerstitial lesions by modifying the Treg/Th17 balance in lupus-prone MRL/lpr mice.
8/2019	Fractalkine is Involved in Lipopolysaccharide-Induced Podocyte Injury through the Wnt/β-Catenin Pathway in an Acute Kidney Injury Mouse Model.
1/2019	FKN Facilitates HK-2 Cell EMT and Tubulointerstitial Lesions via the Wnt/β-Catenin Pathway in a Murine Model of Lupus Nephritis.
1/2018	Upregulated fractalkine levels in Chinese patients with lupus nephritis.
8/2015	Methylprednisolone attenuates lipopolysaccharide-induced Fractalkine expression in kidney of Lupus-prone MRL/lpr mice through the NF-kappaB pathway.
4/2013	[Blood and renal fractalkine expression in patients with lupus nephritis and its significance].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanwu You Research Topics

Disease

5	Lupus Nephritis 01/2020 - 04/2013
4	Proteinuria 08/2022 - 01/2019
3	Acute Kidney Injury (Acute Renal Failure) 08/2022 - 08/2019
3	Inflammation (Inflammations) 01/2021 - 08/2019
3	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2019
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020 - 01/2018
1	Renal Insufficiency (Renal Failure) 08/2022
1	Kidney Diseases (Kidney Disease) 12/2019
1	malar rash 06/2019
1	Arthritis (Polyarthritis) 06/2019
1	Photosensitivity Disorders (Photodermatitis) 06/2019
1	Serositis 06/2019
1	Oral Ulcer (Mouth Ulcer) 06/2019
1	Hyperglycemia 04/2015
1	Pancreatitis 08/2014
1	Sepsis (Septicemia) 11/2013

Drug/Important Bio-Agent (IBA)

9	Chemokine CX3CL1IBA 08/2022 - 04/2013
3	AutoantibodiesIBA 01/2021 - 01/2019
3	CateninsIBA 01/2021 - 01/2019
3	Messenger RNA (mRNA)IBA 01/2018 - 04/2013
2	ChemokinesIBA 01/2021 - 01/2019
2	LipopolysaccharidesIBA 01/2021 - 08/2019
2	nephrinIBA 12/2019 - 04/2015
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 04/2013
1	Biomarkers (Surrogate Marker)IBA 08/2022
1	p38 Mitogen-Activated Protein KinasesIBA 01/2021
1	AngiotensinsIBA 12/2019
1	NPHS2 proteinIBA 12/2019
1	anti-dsDNA autoantibodyIBA 06/2019
1	AntibodiesIBA 06/2019
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Methylprednisolone FDA LinkGeneric 08/2015
1	DesminIBA 04/2015
1	Fas Ligand Protein (Fas Ligand)IBA 08/2014
1	HLA-DR Antigens (HLA-DR)IBA 11/2013
1	EnzymesIBA 04/2013
1	ImmunosorbentsIBA 04/2013